Arxis
ARXS
47.05
-2.44
-4.93%
Arxis
US · ARXS
#882 by market cap
Listed 2026
47.05
-2.44
-4.93%
Live - 5344 symbols - heartbeat 375s ago
· 2026-10-08 07:00
Pre-market
47.00
-0.11%
After-hours
47.05
0.00%
Overnight
48.48
+3.04%
- Market cap
- 20.27B
- P/E (TTM)i
- 153.26
- P/Bi
- 4.54
- EPSi
- -0.12
- Div yieldi
- 0.00%
- 52W posi
- 49%
Reader sentiment
Are you bullish or bearish on ARXS?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Good
- Altman Z-Score is 4.91, above the 3.0 "safe zone" threshold.
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 3 years
Latest year +115.49% YoY
Margins
- Gross margin
- 47.35%
- Operating margin
- 6.74%
- Net margin
- -3.11%
Key ratios & quality
- Enterprise valuei
- 21.61B
- Altman Z-Scorei
- 4.91
Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2023 | 2024 | 2025 |
|---|---|---|---|
| Revenue | 424.50M | 742.99M | 1.60B |
| Gross profit | 194.02M | 331.14M | 758.06M |
| Selling & admin expenses | 88.23M | 156.14M | 509.53M |
| Research & development | -- | -- | -- |
| Operating profit | 54.32M | 102.59M | 107.91M |
| Pretax profit | -69.33M | -53.00M | -64.64M |
| Tax | -9.41M | 2.47M | -14.81M |
| Net profit | -59.92M | -55.47M | -49.83M |
| Basic EPS | 0 | 0 | 0 |
| Diluted EPS | -0.15 | -0.14 | -0.12 |
| Line item | 2025-03 | 2025-06 | 2026-03 | 2026-06 |
|---|---|---|---|---|
| Revenue | 380.08M | 400.44M | 458.86M | 500.73M |
| Gross profit | 162.91M | 197.61M | 234.84M | 262.60M |
| Selling & admin expenses | 68.63M | 80.58M | 88.32M | 193.63M |
| Research & development | -- | -- | -- | -- |
| Operating profit | 60.21M | 82.85M | 110.50M | 32.68M |
| Pretax profit | -6.83M | 29.09M | 69.01M | -1.41M |
| Tax | -2.50M | 58.34M | 15.70M | 3.50M |
| Net profit | -4.32M | -29.26M | 53.31M | -4.91M |
| Basic EPS | 0 | 0 | 0 | 0 |
| Diluted EPS | -0.01 | -0.07 | 0.13 | -0.01 |
Balance sheet
| Line item | 2023 | 2024 | 2025 |
|---|---|---|---|
| Total current assets | -- | 712.06M | 1.21B |
| Cash & ST investments | -- | 110.84M | 561.36M |
| Inventory | -- | 301.95M | 315.60M |
| Total assets | -- | 6.32B | 6.90B |
| Total current liabilities | -- | 263.02M | 240.09M |
| Short-term debt | -- | 35.95M | 29.98M |
| Long-term debt | -- | 2.51B | 1.88B |
| Total liabilities | -- | 3,340,463,000.00 | 2,702,331,000.00 |
| Total equity | -- | 2.98B | 4.20B |
| Retained earnings | -- | -- | -226.44M |
| Line item | 2025-03 | 2025-06 | 2026-03 | 2026-06 |
|---|---|---|---|---|
| Total current assets | -- | -- | 943.95M | 1.24B |
| Cash & ST investments | -- | -- | 238.92M | 494.69M |
| Inventory | -- | -- | 326.00M | 337.70M |
| Total assets | -- | -- | 6.64B | 7.01B |
| Total current liabilities | -- | -- | 255.17M | 236.98M |
| Short-term debt | -- | -- | 37.80M | 11.21M |
| Long-term debt | -- | -- | 2.63B | 1.72B |
| Total liabilities | -- | -- | 3,456,455,000.00 | 2,539,094,000.00 |
| Total equity | -- | -- | 3.18B | 4.47B |
| Retained earnings | -- | -- | -- | -16.11M |
Cash flow
| Line item | 2023 | 2024 | 2025 |
|---|---|---|---|
| Operating cash flow | -7.92M | 70.95M | 251.20M |
| Depreciation & amortization | 65.32M | 96.30M | 200.11M |
| Free cash flow | -20.42M | 42.06M | 208.77M |
| Dividends paid | 0 | 0 | -363.81M |
| Stock buybacks / issuance | 19.87M | 0 | 8.80M |
| Ending cash balance | 11.77M | 110.84M | 250.30M |
| Line item | 2025-03 | 2025-06 | 2026-03 | 2026-06 |
|---|---|---|---|---|
| Operating cash flow | 20.76M | 47.84M | 36.47M | 137.89M |
| Depreciation & amortization | 48.99M | 49.10M | 51.53M | 52.03M |
| Free cash flow | 11.97M | 35.24M | 24.77M | 127.30M |
| Dividends paid | -350.26M | -862.00K | -307.00K | -25.00K |
| Stock buybacks / issuance | -- | -- | -- | -- |
| Ending cash balance | 152.78M | 170.54M | 238.92M | 494.69M |
Returns & efficiency
| Line item | 2023 | 2024 | 2025 |
|---|---|---|---|
| ROE %i | -- | -1.86 | -1.39 |
| ROA %i | -- | -0.88 | -0.75 |
| ROIC %i | -- | 1.29 | 1.40 |
| 5-year avg ROE %i | -- | -- | -- |
| EBIT margin %i | 13.00 | 14.54 | 7.11 |
| FCF / sales %i | -- | 5.66 | 13.04 |
| Current ratioi | -- | 2.71 | 5.06 |
| Quick ratioi | -- | 1.40 | 3.52 |
| Debt / assetsi | -- | 41.06 | 28.39 |
| LT debt / equityi | -- | 85.93 | 45.93 |
| Interest coveragei | 0.44 | 0.67 | 0.64 |
| Revenue CAGR (3Y) %i | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- |
| Line item | 2025-03 | 2025-06 | 2026-03 | 2026-06 |
|---|---|---|---|---|
| ROE %i | -- | -- | 0.25 | 0.72 |
| ROA %i | -- | -- | 0.12 | 0.46 |
| ROIC %i | -- | -- | 1.95 | 1.82 |
| 5-year avg ROE %i | -- | -- | -- | -- |
| EBIT margin %i | -- | -- | 9.85 | 6.57 |
| FCF / sales %i | -- | -- | 13.19 | 17.62 |
| Current ratioi | -- | -- | 3.70 | 5.21 |
| Quick ratioi | -- | -- | 2.20 | 3.58 |
| Debt / assetsi | -- | -- | 40.93 | 25.45 |
| LT debt / equityi | -- | -- | 84.17 | 39.67 |
| Interest coveragei | -- | -- | 1.07 | 0.86 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- |
Quote time 2026-10-08 07:00:14 · For reference only, not investment advice and not tailored to your situation.